BSE Code: 524816 | NSE Code: NATCOPHARM | ISIN: INE987B01026 | Sector: Pharmaceuticals & Drugs
Updated:11 May, 2021, 09:49 AM IST
Updated:11 May, 2021, 09:57 AM IST
Second quarter profit of the company was broadly in-line with estimates. Religare values the base business of Natco Pharma at 18 times its FY18 estimated earnings per share and the filing pipeline at Rs 437 per share.
Market Dashboard
